Showing results (121-130 of 133) with videos related to
Sort By:
Pageof 14
The Journal of Headache and Pain|December 5, 2024
Combining treatments for migraine prophylaxis: the state-of-the-artLanfranco Pellesi, David Garcia-Azorin, Eloisa Rubio-Beltrán, et al.Research Square|September 18, 2025
Symptoms of Allodynia and Pain Thresholds Amongst Those with Acute Post-Traumatic Headache Attributed to Mild Traumatic Brain Injury: A Prospective, Longitudinal StudyNoah Ziff, Gina Dumkrieger, Santiago Garza, et al.Journal of Neurology|January 25, 2025
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE studyPiero Barbanti, Cinzia Aurilia, Paola Torelli, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 18, 2026
Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in ItalyPiero Barbanti, Cristina Tassorelli, Fabrizio Vernieri, et al.Cephalalgia : an International Journal of Headache|March 22, 2024
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injuryHåkan Ashina, Hans-Christoph Diener, Cristina Tassorelli, et al.Headache|November 23, 2019
The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient CohortTodd J Schwedt, Kathleen Digre, Stewart J Tepper, et al.Frontiers in Human Neuroscience|May 7, 2021
Pathophysiological Bases of Comorbidity in MigraineClaudia Altamura, Ilenia Corbelli, Marina de Tommaso, et al.The Journal of Headache and Pain|November 1, 2022
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patientsPiero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.Journal of Neurology|June 28, 2022
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experienceClaudia Altamura, Nicoletta Brunelli, Marilena Marcosano, et al.The Journal of Headache and Pain|October 2, 2025
Application of machine learning in migraine classification: a call for study design standardization and global collaborationIgor Petrušić, Roberta Messina, Lanfranco Pellesi, et al.Pageof 14